Through exploring the upstream and downstream regulatory mechanism of LINC00152, this study provided new insight into the potential use of YAP1/LINC00152/FSCN1 for the development of new treatment strategies for CRC. This evidence concerns the gene CYTOR and colorectal carcinoma.